2019 °³¿øÀǸ¦ À§ÇÑ ½ÉÀåÇ÷°üºÐ¾ß ¿¬¼ö°Á : 2019-10-26±³À°ÀÏÀÚ : 2019-10-26
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ Áø¸®°ü 101°ÀǽÇ
±³À°ÁÖÁ¦ :
2019 °³¿øÀǸ¦ À§ÇÑ ½ÉÀåÇ÷°üºÐ¾ß ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³»°úÇб³½Ç
´ã´çÀÚ : ÀÌÁ¤Èñ
¿¬¶ôó : 033-741-0917
À̸ÞÀÏ :
cardiodata@yonsei.ac.kr ±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
°¿øµµ±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-26 101È£ 14:00~14:15 TAVI for low-risk patients : Pros È«¼øâ(¿øÁÖÀÇ´ë ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 10-26 101È£ 14:15~14:30 TAVI for low-risk patients : Cons ÀÌÁØ¿ø(¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 10-26 101È£ 14:30~14:45 PFO closure in cryptogenic stroke : Neurological perspectives ÀÌÁö¿ë(¿øÁÖÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-26 101È£ 14:45~15:00 PFO closure in cryptogenic stroke : Cardiologic perspectives ¼ÕÁ¤¿ì(¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
Åä·Ð 10-26 101È£ 15:00~15:15 ÆгÎÅäÀÇ ()
ÈÞ½Ä 10-26 101È£ 15:15~15:30 Coffee break ()
±³À°½Ã°£ 10-26 101È£ 15:30~15:45 Non-statin therapy for dyslipidemia À̺À±â(°¿øÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 10-26 101È£ 15:45~16:00 How to manage blood thinners during procedure or surgery? ¾È¼º±Õ(¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 10-26 101È£ 16:00~16:15 Clinical meaning of coronary artery calcium score in medical checkup ÀÓµ¿Áø(¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú)
Åä·Ð 10-26 101È£ 16:15~16:30 ÆгÎÅäÀÇ ()
ÈÞ½Ä 10-26 101È£ 16:30~16:40 »çÁøÃÔ¿µ ()
ÈÞ½Ä 10-26 101È£ 16:40~17:00 Coffee break ()
±³À°½Ã°£ 10-26 101È£ 17:00~17:15 ´Ù¸®°¡ ºÎ¾î¿ä À±¿µÁø(¿øÁÖÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 10-26 101È£ 17:15~17:30 Sleep apnea and cardiovascular disease ±è»óÇÏ(¿øÁÖÀÇ´ë È£Èí±â³»°ú)
±³À°½Ã°£ 10-26 101È£ 17:30~17:45 Aspirin for primary prevention ±è±âÇö(¿ï»êÀÇ´ë ½ÉÀå³»°ú)
Åä·Ð 10-26 101È£ 17:45~18:00 ÆгÎÅäÀÇ ()